Deprecated: abs(): Passing null to parameter #1 ($num) of type int|float is deprecated in /home/individends/public_html/financial_analysis.php on line 303

Profitability Metrics

Gross Margin
2.18%
Operating Margin
91.69%
Net Margin
7.86%

Efficiency Metrics

Revenue per Expense Ratio
10.10
R&D as % of Revenue
0.00%

Earnings Quality

EBITDA Margin
0.00%
Income Tax Rate
0.00%
EPS
0.1400000000

Balance Sheet Analysis

Current Ratio
4.28
Cash Ratio
0.00
Working Capital
$9.35M
Debt to Equity
0.69
Debt to Assets
40.59%
Equity Ratio
59.13%

Cash Flow Analysis

Operating Cash Flow Ratio
58.45%
Free Cash Flow Ratio
58.45%
CapEx to Revenue
0.00%
Dividends Paid
$51.09M
Stock Buybacks
No buybacks
Total Shareholder Returns
$51.09M
Cash Position Change
2,949,030,900.0%

Key Takeaways (2023 FY)

  • Maintained positive net income growth despite revenue changes
  • Increased R&D investment by 100.00%

Detailed Growth Metrics

Core Performance

Revenue
155.96%
Net Income
104.35%
EPS
104.35%
Operating Income
154.62%

Operational Efficiency

R&D Expenses
100.00%
SG&A Expenses
510.22%
Operating Cash Flow
-3.07%
Free Cash Flow
-3.07%

Balance Sheet Health

Assets
-3.32%
Debt
0.00%
Book Value per Share
-5.74%
Inventory
0.00%

Shareholder Returns

Dividends per Share
-19.01%
Shares Outstanding
0.17%

Long Term Trends

3Y Revenue/Share
8.19%
5Y Revenue/Share
294.50%
3Y Dividend/Share
-20.89%
5Y Dividend/Share
-22.01%